FDA approves initiation of STEMI DTU pivotal randomized controlled trial
Image: The STEMI DTU safety and feasibility trial demonstrates the potential to reduce infarct size in STEMI. Photo: Courtesy of BUSINESS WIRE.
NS Medical Devices is using cookies
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X